A Study of CS1-targeted CAR-T Cells Therapy for Relapsed Multiple Myeloma After BCMA CAR-T Cells Therapy
Condition(s):Relapse Multiple MyelomaLast Updated:December 10, 2020Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Relapse Multiple MyelomaLast Updated:December 10, 2020Not yet recruiting
Condition(s):Multiple Myeloma; Multiple Myeloma in Relapse; Multiple Myeloma ProgressionLast Updated:December 14, 2018Unknown status
Condition(s):Multiple MyelomaLast Updated:June 15, 2021Unknown status
Condition(s):Multiple MyelomaLast Updated:June 4, 2019Unknown status
Condition(s):Multiple Myeloma in RelapseLast Updated:August 21, 2019Unknown status
Condition(s):Multiple MyelomaLast Updated:January 30, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:December 24, 2015Completed
Condition(s):Multiple MyelomaLast Updated:August 28, 2023Completed
Condition(s):Multiple MyelomaLast Updated:November 14, 2022Completed
Condition(s):Multiple MyelomaLast Updated:August 16, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.